300717-27-5

Basic information

• Product Name: N-phenethyl-2,2-diphenylacetamide
• Synonyms: N-phenethyl-2,2-diphenylacetamide
• CAS NO: 300717-27-5
• Molecular Weight: 315.415
• Mol File: 300717-27-5.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: N-phenethyl-2,2-diphenylacetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-phenethyl-2,2-diphenylacetamide(300717-27-5)
• EPA Substance Registry System: N-phenethyl-2,2-diphenylacetamide(300717-27-5)

Safety Data

• Hazardous Substances Data: 300717-27-5(Hazardous Substances Data)

Upstream product

• 1871-76-7 diphenylacetic acid chloride 
• 64-04-0 phenethylamine 
• 117-34-0 2,2-diphenylacetic acid 
• 51-67-2 tyrosamine 
• 768-94-5 1-Adamantanamine 
• 3261-62-9 2-(p-tolyl)ethylamine 
• 120-20-7 2-(3,4-dimethoxyphenyl)-ethylamine 
• 99-94-5 p-Toluic acid 
• 55-81-2 4-Methoxyphenethylamine 
• 24313-88-0 3,4,5-Trimethoxyaniline 
• 2039-67-0 2-(3-methoxyphenyl)-1-ethanamine 
• 2045-79-6 o-methoxy-2-phenylethylamine 
• 299-42-3 2-methylamino-1-phenylpropanol 
• 94598-40-0 2,2,2-trichloroethyl diphenylacetate 

Relevant articles and documents

Facile direct synthesis of amides from trichloroethyl esters using catalytic DBU

A practical method for the direct synthesis of amide compounds is described. Using small quantities of DBU as a catalyst, the direct conversion of 2,2,2-trichloroethyl esters to their corresponding amides was readily achieved. Based on this protocol, various amide compounds were successfully synthesized in high yield, suggesting a promising approach for the practical one-pot aminolysis from 2,2,2-trichloroethyl protected esters.

Tetrabenzylpyrophosphate: An efficient catalyst for the synthesis of carboxamides from carboxylic acids and amines

An efficient method for the synthesis of simple and sterically hindered carboxamides from various carboxylic acids and amines using tetrabenzylpyrophosphate (TBPP) as a coupling agent in the presence of 4-(dimethylamino)pyridine (DMAP) is described. The r

COMPOUNDS AND METHODS FOR TREATMENT OF CANCER AND MODULATION OF PROGRAMMED CELL DEATH FOR MELANOMA AND OTHER CANCER CELLS

Compounds and related methods for synthesis, and the use of compounds and combination therapies for the treatment of cancer and modulation of apoptosis in cells are disclosed. The generation of synthetic combinatorial libraries and the evaluation of library member compounds regarding induction of apoptosis selectively in cancer cells are disclosed. Compounds, methods of making the compounds, and therapeutic methods with application against breast cancer cells, melanoma cancer cells, colon cancer cells, and other cancer cells are described.